Skip to main content
CVSA
NYSE Trade & Services

Strong Q3 Performance Leads Covista to Boost Full-Year Outlook

Reported by Wiseek News
Sentiment info
Positive
Importance info
8
Price
$119.51
Mkt Cap
$4.037B
52W Low
$86.97
52W High
$156.26
Market data snapshot near publication time

Summary

Covista Inc. reported robust third-quarter fiscal 2026 results, with revenue reaching $487.0 million and adjusted diluted EPS of $1.98. Crucially, the company raised its full-year fiscal 2026 revenue and adjusted EPS guidance, signaling a positive outlook. This strong performance was supported by significant enrollment growth, with total student enrollment surpassing 100,000 for the first time, and record enrollments at Chamberlain and Walden. This news, directly following the company's 8-K filing, provides fresh and material information. The raised guidance and operational strength are significant for the stock, indicating improved financial health and execution. Investors will be watching for continued enrollment momentum and the successful launch of new programs and campuses.

At the time of this announcement, CVSA was trading at $119.51 on NYSE in the Trade & Services sector, with a market capitalization of approximately $4B. The 52-week trading range was $86.97 to $156.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CVSA - Latest Insights

CVSA
May 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $119.51
Real-time Price: $117.34 info
Change: -$2.17 (-2%) info
Market Cap: $3.993B info
CVSA
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $119.51
Real-time Price: $117.34 info
Change: -$2.17 (-2%) info
Market Cap: $3.993B info
CVSA
Apr 09, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $118.00
Real-time Price: $117.34 info
Change: -$0.660 (-0.56%) info
Market Cap: $3.993B info